Published on March 13, 2013 at 9:44 AM
Politico: Brand-Name, Generic Drugmakers Fight FTC
Brand and generic drug companies are usually at each other' throats. But they will stand shoulder to shoulder against the Federal Trade Commission and other health care interests come March 25, when the Supreme Court will hear oral arguments about a controversial way of settling patent disputes that's worth billions to the drug industry (Norman, 3/12).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.